[Form 4] Peraso, Inc. Insider Trading Activity

Rhea-AI Filing Summary

James Sullivan, Chief Financial Officer of Peraso Inc. (PRSO), reported acquisition of stock options granting the right to purchase 25,000 shares of common stock at an exercise price of $0.8399 per share, with a transaction date of 08/07/2025. The options vest at 1/36th of the shares on each monthly anniversary following 08/07/2025 and are reported as held directly by the reporting person. The filing lists a date of 08/07/2035 in the date/exercise expiration field and reports total derivative holdings of 25,000 options. The explanation clarifies the monthly vesting schedule and notes that column reporting covers only the listed derivative class.

Positive

• Reported acquisition of 25,000 stock options exercisable at $0.8399 per share
• Vesting schedule explicitly stated as 1/36th monthly following 08/07/2025
• Options are reported as held directly by the reporting person

Negative

• Table shows a $0.00 entry in a price field for the derivative security, which may require clarification
• Form 4 reporting covers only this derivative class; prior holdings or other award classes are not detailed

Insights

Financial Analyst

TL;DR: Routine executive option grant; 25,000 options at $0.8399 with monthly vesting over 36 months, direct ownership reported.

The Form 4 discloses a grant of 25,000 stock options to the CFO with an exercise price of $0.8399. The options were transacted on 08/07/2025, vest at 1/36th per month thereafter and are shown as directly owned. The filing lists 08/07/2035 in the date/exercise expiration field and reports total derivative holdings of 25,000 options for this derivative class. This is a standard long-term incentive award as reported; the Form does not disclose any cash consideration beyond the stated exercise price or other classes of outstanding awards.

Corporate Governance Expert

TL;DR: Disclosure is specific on vesting and quantity but limited to this derivative class; no material governance red flags apparent in the record.

The filing clearly states the grant terms: 25,000 options, $0.8399 exercise price, monthly vesting at 1/36th following 08/07/2025, and direct ownership. The explanatory note clarifies column reporting conventions for derivative classes. The table shows a $0.00 entry in a price field which may reflect reporting layout rather than economic detail; the Form does not provide additional context about board approval or other outstanding award classes. Based solely on the disclosed items, this appears to be a routine equity incentive disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SULLIVAN JAMES

(Last) (First) (Middle)

2033 GATEWAY PLACE

SUITE 500

(Street)

SAN JOSE CA 95110

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Peraso Inc. [ PRSO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$0.8399	08/07/2025		A		25,000		(1)	08/07/2035	Common Stock	25,000	$0.00	25,000(2)	D

Explanation of Responses:

1. The option will vest as to 1/36th of the shares subject to the option on each monthly anniversary following August 7, 2025.

2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

	/s/ James Sullivan	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Peraso (PRSO) CFO James Sullivan report on Form 4?

He acquired 25,000 stock options to purchase common stock at an exercise price of $0.8399 per share, transaction date 08/07/2025.

How do the options granted to PRSO's CFO vest and when do they expire?

The options vest at 1/36th of the shares on each monthly anniversary following 08/07/2025; the filing lists 08/07/2035 in the date/exercise expiration field.

How many shares underlie the derivative security reported by PRSO's CFO?

The derivative security covers 25,000 underlying shares of common stock.

What role does the reporting person hold at Peraso (PRSO)?

James Sullivan is reported as an officer: Chief Financial Officer.

Is the reported ownership direct or indirect?

The Form 4 reports the options as held Directly by the reporting person.